Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)

Clinical trial NCT03682055 · TERMINATED

Trial details

NCT number: NCT03682055
Sponsor: Cullinan Therapeutics Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Nasopharyngeal Cancer

Start date: 2019-04-04
Primary completion: 2020-06-23
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.